Obviously the good Dr. did more than run an animal testing lab
I appreciate all replies to my query. I think it remains that no one here has any independent knowledge (that they are willing to provide) that would help someone assess the validity or significance of what the CTIX web site states about Dr. Menon's involvement at Lilly.
I appreciate the two scientific article info that BK provided. But if you know how this works, being the 3rd or 4th author in a multi-author scientific journal article does not suggest any lead role in regard to that study. Anyone from a research assistant on who actually carried out experiments under someone's direction can be entitled to partial authorship depending on their contribution to the particular paper. One would assume that Dr. M, based on his degrees, would have been above a research assistant level any way.
It would be helpful to know what Dr. Menon's actual job title was at Lilly. This has nothing to do with Kevetrin or Brilacidin's potential, but everything to do with the credibility of the management. For the many wondering why big money is not getting into this company, here may be clues.
I know a lot of you have a lot of money riding on this and I do not wish any loss for anyone or for myself, for that matter. Truth sometimes is the best insurance.
Market Data 
Markets 
AI
